Valuation: DarioHealth Corp.

Market Cap 12.35M 11.22M 10.36M 9.36M 17.67M 1.16B 18.29M 125M 49.39M 622M 46.33M 45.35M 1.97B P/E 2026 *
-0.31x
P/E 2027 * -0.56x
Enterprise Value 23.69M 21.53M 19.89M 17.97M 33.9M 2.22B 35.1M 239M 94.77M 1.19B 88.91M 87.03M 3.78B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 1.29x
Free-Float
68.02%
Yield 2026 *
-
Yield 2027 * -
1 day+6.35%
1 week-34.95%
Current month-55.33%
1 month-72.20%
3 months-81.79%
6 months-83.95%
Current year-88.22%
1 week 1.09
Extreme 1.09
3.02
1 month 1.09
Extreme 1.09
5.32
Current year 1.09
Extreme 1.09
13.64
1 year 1.09
Extreme 1.09
14.77
3 years 1.09
Extreme 1.09
52
5 years 1.09
Extreme 1.09
340.9
10 years 1.09
Extreme 1.09
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 68 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap. Importance
9/24/26 A Free

Chairman

54,000 0.5510%
9/24/26 A Free

Director

61,000 0.6225%
9/24/26 A Free

Director

28,000 0.2857%
Change 5-day change 1-year change 3-year change Capi.($)
+6.35%-34.95%-90.41%-93.37% 12.35M
-0.40%-1.91%-16.63%+8.12% 188B
+0.36%+0.64%+7.45%+38.15% 126B
+0.30%-4.35%-13.49%+6.87% 118B
+1.18%-3.20%-41.54%+3.72% 92.48B
-0.25%+3.57%-1.88%+81.87% 68.51B
-0.45%+1.17%+14.03%-7.36% 59.39B
-0.03%+0.10%+5.73%+51.58% 55.48B
-2.26%+4.42%-3.31%+45.02% 49.62B
+1.27%+1.50%+1.21%-0.19% 35.17B
Average +0.67%-3.64%-13.88%+13.44% 79B
Weighted average by Cap. +0.04%+0.03%-8.48%+22.39%

Financials

2026 *2027 *
Net sales 21.78M 19.78M 18.28M 16.51M 31.16M 2.04B 32.26M 220M 87.1M 1.1B 81.71M 79.98M 3.48B 29.1M 26.44M 24.43M 22.07M 41.64M 2.73B 43.11M 294M 116M 1.47B 109M 107M 4.65B
Net income -33.13M -30.1M -27.81M -25.12M -47.4M -3.11B -49.07M -334M -132M -1.67B -124M -122M -5.29B -21.31M -19.36M -17.89M -16.16M -30.49M -2B -31.56M -215M -85.22M -1.07B -79.95M -78.26M -3.4B
Net Debt 11.35M 10.31M 9.52M 8.6M 16.24M 1.07B 16.81M 115M 45.38M 572M 42.58M 41.68M 1.81B 25.07M 22.78M 21.05M 19.01M 35.88M 2.35B 37.14M 253M 100M 1.26B 94.08M 92.09M 4B
Projected Income Statement - Annual - DarioHealth Corp.
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
16/11/26 $1.340 +6.35% 78,230
13/11/26 $1.260 -23.64% 74,832
12/11/26 $1.650 -22.35% 152,217
11/11/26 $2.125 -11.09% 78,279
10/11/26 $2.390 +16.02% 59,351
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.260USD
Average target price
8.200USD
Spread / Average Target
+550.79%
  1. Stock Market
  2. Stocks
  3. DRIO Stock